An Update on Select Topics in Chronic Rhinosinusitis With Nasal Polyps

Authors

  • Doron D. Sommer, MD, FRCSC
  • Tobial McHugh, MD, FRCSC

DOI:

https://doi.org/10.58931/cait.2021.1320

Abstract

Chronic rhinosinusitis affects approximately 5-15% of the population and has an economic burden estimated to be between $22 – $64.5 billion US dollars per year. The condition causes significant reductions in quality of life, productivity and emotional wellbeing for patients. Furthermore it is a top ten leading cause of employee absenteeism.

Author Biographies

Doron D. Sommer, MD, FRCSC

Dr. Doron Sommer is an otolaryngologist/head and neck surgeon and Clinical Professor at McMaster University. He completed his medical studies and residency in otolaryngology at the University of Toronto and went on to advanced training in Facial Plastic Surgery. He also specializes in rhinology and endoscopic skull base surgery as well as minimally invasive surgical techniques in otolaryngology. He has research interests in surgical techniques in rhinology/skull base surgery, pediatric sleep apnea, smoking cessation and surgical flow and safety measures. He has published many peer reviewed publications as well as several book chapters, and has given numerous lectures, courses and workshops at national and international surgical meetings. Dr. Sommer is an active member of several professional societies and is currently the co-chair of the Royal College of Physicians and Surgeons of Canada otolaryngology examination board.

Tobial McHugh, MD, FRCSC

Dr. Tobial McHugh is dual fellowship trained in pediatric otolaryngology and most recently in rhinology, anterior skull base surgery. He completed otolaryngology, head and neck surgery residency training at McMaster University and his medical degree at McGill University. Research interests include pediatric otolaryngology, anterior skull base pathologies, allergy, and rhinosinusitis. Dr. McHugh will be planning to combine both his fellowships with a special interest in pediatric anterior skull base pathologies and surgery.

References

Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: A systematic review. Laryngoscope. 2015 July;125(7):1547-56. doi:10.1002/lary.25180

Caulley L, Thavorn K, Rudmik L, et al. Direct costs of adult chronic rhinosinusitis by using 4 methods of estimation: Results of the US Medical Expenditure Panel Survey. J Allergy Clin Immunol. 2015 Dec;136(6):1517-22. doi:10.1016/j.jaci.2015.08.037

Klonaris D, Doulaptsi M, Karatzanis A, et al. Assessing quality of life and burden of disease in chronic rhinosinusitis: a review. Rhinology Online. 2019 Aug;2:6-13.

Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-S39. doi:10.1177/0194599815572097

Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020 Feb 20;58(Suppl S29):1-464. doi:10.4193/Rhin20.600

McHugh T, Snidvongs K, Xie M, et al. High tissue eosinophilia as a marker to predict recurrence for eosinophilic chronic rhinosinusitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2018 Dec;8(12):1421-9. doi:10.1002/alr.22194

Ho J, Hamizan AW, Alvarado R, et al. Systemic Predictors of Eosinophilic Chronic Rhinosinusitis. Am J Rhinol Allergy. 2018 Jul;32(4):252-7. doi:10.1177/1945892418779451

Ho J, Earls P, Harvey RJ. Systemic biomarkers of eosinophilic chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2020 Feb;20(1):23-29. doi:10.1097/ACI.0000000000000602

McHugh T, Snidvongs K, Xie M, et al. High tissue eosinophilia as a marker to predict recurrence for eosinophilic chronic rhinosinusitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2018 Dec;8(12):1421-9. doi:10.1002/alr.22194

Seresirikachorn K, Kerr SJ, Aeumjaturapat S, et al. Predictive factors for identifying macrolide responder in treating chronic rhinosinusitis. Rhinology. 2021 Jun 1;59(3):284-291. doi: 10.4193/Rhin20.649

DelGaudio JM, Loftus PA, Hamizan AW, et al. Central compartment atopic disease. Am J Rhinol Allergy. 2017 Jul 1;31(4):228-34. doi:10.2500/ajra.2017.31.4443

Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020 Feb 20;58(Suppl S29):1-464. doi:10.4193/Rhin20.600

Stevens WW, Peters AT, Tan BK, et al. Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis. J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2812-2820.e3. doi:10.1016/j.jaip.2019.05.009

Cao PP, Wang ZC, Schleimer RP, Liu Z. Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes. Ann Allergy Asthma Immunol. 2019 Jan;122(1):33-40. doi:10.1016/j.anai.2018.10.014

Philpott CM, Smith R, Davies-Husband CR, et al. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study. Rhinology. 2019 Aug;57(4):303-12. doi:10.4193/Rhin19.027

Stevens WW, Peters AT, Hirsch AG, Nordberg CM, Schwartz BS, Mercer DG, et al. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1061-70.e3. doi:10.1016/j.jaip.2016.12.027

Levy JM, Rudmik L, Peters AT, et al. Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2016 Dec;6(12):1273-83. doi:10.1002/alr.21826

Fruth K, Pogorzelski B, Schmidtmann I, et al. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease. Allergy. 2013;68:659-65. doi:10.1111/all.12131

Grayson JW, Cavada M, Harvey RJ. Clinically relevant phenotypes in chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2019 May;48(1):23. doi:10.1186/s40463-019-0350-y

Younis RT, Anand VK, Davidson B. The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications. Laryngoscope. 2002 Feb;112(2):224-9. doi:10.1097/00005537-200202000-00005

Bhattacharyya N. A comparison of symptom scores and radiographic staging systems in chronic rhinosinusitis. Am J Rhinol. 2005 Mar-Apr;19(2):175-9.

Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 1997 Sep;117(3 Pt 2):S35-40. doi:10.1016/S0194-59989770005-6

Hopkins C, Gillett S, Slack R, et al. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009 Oct;34(5):447-54. doi:10.1111/j.1749-4486.2009.01995.x

Rudmik L, Soler ZM, Mace JC, et al. Using preoperative SNOT-22 score to inform patient decision for Endoscopic sinus surgery. Laryngoscope. 2015 Jul;125(7):1517-22. doi:10.1002/lary.25108

Rudmik L, Soler ZM, Hopkins C. Using postoperative SNOT-22 to help predict the probability of revision sinus surgery. Rhinology. 2016 Jun;54(2):111-6. doi:10.4193/Rhino15.284

Fokkens WJ, Lund VJ, Mullol J, Babchert C, Alobid I, Baroody F, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012 Mar;50(1):1-12. doi:10.4193/Rhino12.000

Masterson L, Tanweer F, Bueser T, Leong P. Extensive endoscopic sinus surgery: does this reduce the revision rate for nasal polyposis?. Eur Arch Otorhinolaryngol. 2010 Oct;267(10):1557-1561. doi:10.1007/s00405-010-1233-z

Harvey RJ, Goddard JC, Wise SK, Schlosser RJ. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. Otolaryngol Head Neck Surg. 2008 Jul;139(1):137-42. doi:10.1016/j.otohns.2008.04.020

Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. J Allergy Clin Immunol.2017 Oct;140(4):1024-31.e14. doi:10.1016/j.jaci.2017.05.044

Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011 Nov;128:988-9. doi:10.1016/j.jaci.2011.07.056

Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, Van Zele T, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol. 2006 Nov;118(5):1133-41. doi:10.1016/j.jaci.2006.05.031

Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2013 Jan;131(1):110-6.e1. doi:10.1016/j.jaci.2012.07.047

Tsetsos N, Goudakos JK, Daskalakis D, Konstantinidis I, Markou K. Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review. Rhinology. 2018 Mar 1;56:11-21. doi:10.4193/Rhino17.156

Bachert C, Zinreich SJ, Hellings PW, Mullol J, Hamilos DL, Gevaert P, et al. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP. Rhinology. 2020 Feb 1;58(1)10-17. doi:10.4193/Rhin18.282

Bachert C, Hellings PW, Mullol J, Hamilos D, Gevaert P, Naclerio RM, et al. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020 Jan;75(1):148-157. doi:10.1111/all.13984

Bachert C, Hellings PW, Mullol J, Naclerio RM, Chao J, Amin N, et al. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol.Pract 2019 Sep-Oct;7(7):2447-2449.e2. doi:10.1016/j.jaip.2019.03.023

Claim Secure Drug Review. DUPIXENT Breakthrough Treatment for Severe Atopic Dermatitis. Accessed May 26, 2021. Available from: https://www.claimsecure.com/en/drug-reviews-blog/2018/september/dupixent-drug-review/.

Scangas GA, Wu AW, Ting JY, et al. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps. Laryngoscope. 2021 Jan;131(1):E26-e33. doi:10.1002/lary.28648

Thamboo A, Kilty S, Witterick I, Chan Y, Chin CJ, Janjua A, et al. Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2021 Mar 9;50(1):15. doi:10.1186/s40463-021-00493-2

An Update on Select Topics in Chronic Rhinosinusitis With Nasal Polyps

Downloads

Published

2021-06-01

How to Cite

1.
Sommer DD, McHugh T. An Update on Select Topics in Chronic Rhinosinusitis With Nasal Polyps. Can Allergy Immunol Today [Internet]. 2021 Jun. 1 [cited 2024 Sep. 16];1(3):6–14. Available from: https://canadianallergyandimmunologytoday.com/article/view/1-3-sommer_mchugh

Issue

Volume 1, Issue 3, December 2021

Section

Articles